Our recent reports illustrate that KBD demonstrates multiple modes of action against multiple targets in the AD pathological cascade, including inhibiting AChE, scavenging free radicals, inhibiting amyloid aggregation, neuroprotection, and the improvement of cognitive impairment induced by chronic mild stress in mice [29,30]. This evidence concerns the gene ACHE and Cognitive impairment.